Skip to Main Content

Paper Details

Endomembrane targeting of human OAS1 p46 augments antiviral activity.
Elife
37
2021
COVID-19, OAS1, OAS1 p46, OAS1 p46 isoform, OAS1 splice-site SNP, RNA, SARS, SARS-CoV-2, cytosol, human, human OAS1 p46, innate, innate immune sensors, oligoadenylate synthetase 1, organelle, p46, viral RNA, viral replication sites
Author NameAffiliation
Frank W SovegUniversity of Washington
Frank W SovegCenter for Innate Immunity and Immune Disease, University of Washington
Nandan S GokhaleUniversity of Washington
Nandan S GokhaleCenter for Innate Immunity and Immune Disease, University of Washington
Karen CerosalettiBenaroya Research Institute at Virginia Mason
Cate SpeakeBenaroya Research Institute at Virginia Mason
Vineet D MenacheryUniversity of Texas Medical Center
John Kenneth BaillieRoslin Institute, University of Edinburgh
John Kenneth BaillieInstitute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital
Jane H BucknerBenaroya Research Institute at Virginia Mason
Michael GaleUniversity of Washington
Michael GaleCenter for Innate Immunity and Immune Disease, University of Washington
  • 1 - 12

Datasets

Release 1.2